(Q44920986)

English

Post-chemotherapeutic administration of interleukin-12 retards tumor growth and enhances immune cell function: combination therapy using paclitaxel and IL-12.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Post-chemotherapeutic administration of interleukin-12 retards tumor growth and enhances immune cell function: combination therapy using paclitaxel and IL-12. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jennifer S Pressley

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Klaus D Elgert

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

351-359

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Cytokines as a link between innate and adaptive antitumor immunity.

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Tumor-induced immune dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Potential Prophylactic Measures Against Postoperative Immunosuppression: Could They Reduce Recurrence Rates in Oncological Patients?

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

IL-12 treatment of endogenously arising murine brain tumors.

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

TNF-alpha and IL-12: a balancing act in macrophage functioning

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle.

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Immunobiology of interleukin-12.

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Tumor growth modulates macrophage nitric oxide production following paclitaxel administration.

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Effect of new investigational drug taxol on oncolytic activity and stimulation of human lymphocytes

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production.

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model

1 reference

https://api.crossref.org/works/10.1080%2F07357900600705276

21 January 2018

Identifiers

10.1080/07357900600705276

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44920986&oldid=1561646108"